Indivior (NASDAQ:INDV) Shares Down 5.3% – Here’s Why

Shares of Indivior PLC (NASDAQ:INDV) were down 5.3% during trading on Monday . The company traded as low as $37.86 and last traded at $37.9030. 1,329,739 shares changed hands during mid-day trading, a decline of 38% from the average session volume of 2,133,043 shares. The stock had previously closed at $40.01.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on INDV shares. Craig Hallum reiterated a “buy” rating and set a $53.00 price objective on shares of Indivior in a research note on Tuesday. Zacks Research cut shares of Indivior from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 29th. Barclays reaffirmed an “overweight” rating and set a $43.00 price target on shares of Indivior in a report on Wednesday. Finally, Weiss Ratings upgraded shares of Indivior from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, July 24th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $45.17.

Indivior Price Performance

The stock has a market cap of $4.45 billion, a P/E ratio of 18.72 and a beta of 0.86. The business’s fifty day moving average price is $39.15 and its 200 day moving average price is $35.53.

Indivior (NASDAQ:INDV) last announced its quarterly earnings results on Tuesday, June 30th. The company reported $5.75 earnings per share (EPS) for the quarter. The company had revenue of $343.00 million for the quarter. Indivior had a net margin of 26.65% and a negative return on equity of 310.69%. On average, analysts predict that Indivior PLC will post 4.05 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Indivior news, insider Christian Heidbreder sold 18,586 shares of the firm’s stock in a transaction that occurred on Friday, July 10th. The shares were sold at an average price of $41.14, for a total value of $764,628.04. Following the sale, the insider owned 209,337 shares in the company, valued at $8,612,124.18. This trade represents a 8.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Ryan Preblick sold 36,000 shares of the business’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $37.70, for a total transaction of $1,357,200.00. Following the sale, the chief financial officer directly owned 284,751 shares in the company, valued at approximately $10,735,112.70. The trade was a 11.22% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.74% of the company’s stock.

Institutional Investors Weigh In On Indivior

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Goldman Sachs Group Inc. raised its position in Indivior by 18.4% in the first quarter. Goldman Sachs Group Inc. now owns 8,368,996 shares of the company’s stock valued at $79,757,000 after purchasing an additional 1,299,425 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its stake in shares of Indivior by 101.0% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,371,534 shares of the company’s stock valued at $228,611,000 after buying an additional 3,201,639 shares during the period. Vanguard Group Inc. grew its holdings in Indivior by 57.9% during the 4th quarter. Vanguard Group Inc. now owns 5,473,891 shares of the company’s stock worth $196,403,000 after acquiring an additional 2,008,078 shares during the last quarter. State Street Corp increased its position in Indivior by 65.5% in the 4th quarter. State Street Corp now owns 4,659,281 shares of the company’s stock valued at $167,175,000 after acquiring an additional 1,844,532 shares during the period. Finally, Rubric Capital Management LP raised its stake in shares of Indivior by 31.6% during the second quarter. Rubric Capital Management LP now owns 4,647,179 shares of the company’s stock valued at $68,499,000 after acquiring an additional 1,117,140 shares during the last quarter. Institutional investors own 60.33% of the company’s stock.

Indivior Company Profile

Indivior plc is a specialty pharmaceutical company dedicated to developing and delivering treatments for addiction and related mental health disorders. The company’s portfolio centers on therapies designed to support individuals dealing with opioid dependence, alcohol use disorder and other behavioral health challenges. Its lead products include Suboxone® (buprenorphine and naloxone) sublingual film and Sublocade® (extended-release buprenorphine) injection, both of which are approved in multiple markets to aid in opioid use disorder management.

Indivior was established in 2014 through a demerger from the pharmaceuticals division of Reckitt Benckiser Group plc, inheriting decades of research and commercial expertise in addiction medicine.